Reckitt Benckiser sued by 35 US states for 'profiteering' from opioid treatment

British multinational is accused of ‘shamelessly preying on patients in need of help’ by keeping Suboxone, a drug used to treat addiction, at an inflated price

Dozens of US states have accused a British multinational company of “shamelessly preying on patients in need of help” by profiteering from a drug at the forefront of combating America’s opioid epidemic.

Thirty-five states are suing Reckitt Benckiser for allegedly running “an unlawful, multi-pronged scheme” using patent laws and false safety concerns to dominate the market and maintain an artificially high price for Suboxone, a drug used to fight addiction to prescription painkillers and heroin. Federal authorities have been investigating the company over similar issues for the past four years.

Related: Daraprim ‘profiteering’ controversy lifts lid on soaring cost of prescription drugs

Continue reading…

Pharmaceutical Stocks

[stock-ticker]

© 2017 Drugs News All rights reserved.       Privacy Policy       Contact Us